Boehringer Ingelheim GmbH EuroCharity's RSS for Boehringer Ingelheim GmbH en 2010 20th Wednesday of October 2021 12:35:57 AM 20th Wednesday of October 2021 12:35:57 AM en 2010 Logo Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity Obesity is a complex cardiometabolic disease with growing global prevalence and limited treatment options that are not sufficiently effective or are associated with adverse events 2021-03-23 13:03:00 15879 2010-03-23T15:57:28Z Award: Boehringer Ingelheim is Global Top Employer 2021 Boehringer Ingelheim performs particularly well in strategy, corporate culture and employee involvement 2021-02-23 13:02:27 15845 2010-03-23T15:57:28Z Boehringer Ingelheim partners with PetMedix Strengthening partnerships to accelerate innovation and growth is now one of the key elements of Boehringer Ingelheim’s refocused strategy 2021-01-12 14:01:45 15779 2010-03-23T15:57:28Z Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D Boehringer Ingelheim has set up a dedicated Quantum Lab with leading experts 2021-01-12 13:01:47 15778 2010-03-23T15:57:28Z Boehringer Ingelheim: New SARS-CoV-2 Neutralizing Antibody enters Clinical Phase Virus neutralizing antibodies are expected to become an important line of defense against SARS-CoV-2, complementing vaccines and nonpharmaceutical interventions 2020-12-21 16:12:31 15763 2010-03-23T15:57:28Z